# Pfizer Service Company · 66-66 · BELGIUM — FDA import alert red lists: firms subject to detention without physical examination

For Pfizer Service Company · 66-66 · BELGIUM, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is BELGIUM; product code is 62 O - - 27 Doxazosin Mesylate (Anti-Hypertensive - Part II); date published is 09/30/2009; address is Zaventem , Hoge Wei 10 , Zaventem, Vlaams-Brabant BELGIUM, verified against its source on 2026-09-16.

- **Firm:** Pfizer Service Company _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** BELGIUM _(verified: appears in the quote below)_
- **Address:** Zaventem , Hoge Wei 10 , Zaventem, Vlaams-Brabant BELGIUM _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 62 O - - 27 Doxazosin Mesylate (Anti-Hypertensive - Part II) _(verified: appears in the quote below)_
- **FDA notes:** 11/2/2000 _(verified: appears in the quote below)_

## What the source says

> Pfizer Service Company Date Published : 09/30/2009 Zaventem , Hoge Wei 10 , Zaventem, Vlaams-Brabant BELGIUM 62 O - - 27 Doxazosin Mesylate (Anti-Hypertensive - Part II) Date Published: 09/30/2009 Notes: 11/2/2000

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).